INTRODUCTION
Jadelle is a sub-dermal implant which provides safe, convenient, highly efficacious and long term method of fertility regulation to married and other sexually active women. [1] [2] [3] Jadelle is a contraceptive system that consists of two implantable 43mm rods, each consisting of a drugreleasing core encased in thin-walled silicone rubber tubing sealed at both ends. The core of each rod consists of 50% by weight of levonorgestrel, 75mg and 50% of elastomer. The calculated mean daily in vivo release rate of levonorgestrel provided by the implants is about 100µg/day at the first month, followed by a decline to about 40µg/day at 12months, and to about 30µg/day at 24months, with a stabilization thereafter at about 30µg/day. rod users in seven countries. These trials provided assuring data on blood levels, safety and efficacy of Jadelle. 7, 8 The use of Jadelle was subsequently approved by several countries across Europe, America and parts of Asia. 8 Women tend to try different contraceptive methods during their reproductive life, ostensibly in search of an ideal method. This trend may be influenced by the woman's age, marital status, health status and lifestyle. Jadelle seems to be favoured and accepted by a large proportion of women in both developed and developing countries. 9, 10, 11 The majority of women who choose Jadelle do so because of their dissatisfaction with other methods of contraception, and a large proportion of the implants users find it convenient and highly effective in the prevention of unwanted pregnancies.
12-14 Many women discontinue Jadelle however when they decide to become pregnant, although the commonest reason for early discontinuation is irregular prolonged uterine bleeding. 15, 16 Implants are not associated with long term health risks, and may be used safely in women with contraindications to estrogen-containing contraceptives. The effect it has on the cervical mucus by thickening it may be beneficial as it protects against ascending upper genital tract infections. 17, 18 Notwithstanding the high efficacy and other benefits of implants, the method requires a minor surgical procedure for both insertion and removal, and these are dependent on the health provider. In addition, they can be visible and palpable at the site of insertion and they do not protect against sexually transmitted infections. 19 Similar to other progestin-only contraceptives, Jadelle causes alterations in the normal pattern of menstrual bleeding; this may be in form of irregular menstrual bleeding, prolonged menstrual bleeding or cessation of menstruation. 8 Non menstrual side effects of implants, which may occur infrequently include headache, acne, mastalgia, weight changes, and mood changes. 15, 17 Most serious side effects of implants are progestindependent and they are prevalent during the first 12months of usage; such side effects could compel affected women to discontinue the method, therefore this study was designed to assess the side effect profile of Jadelle implant in Nigerian women during the first 12months of usage in order to appraise their acceptance of the method. 20 The people of the state are predominantly government employed civil servants, and other persons indulging in peasant farming, petty trading and small scale businesses. 20 
METHODS

Study design and study area
Data collection and analysis
Approval was obtained from the University of Uyo Teaching Hospital Ethical Committee before commencement of the study. The nurses working in the Family Planning Unit of the hospital who were six in number were intimated on the nature and purpose of the study and trained on how to administer the data sheets to clients who opted for Jadelle implants during the period of the study. They were instructed on the need to follow up the clients at 6monthly intervals for the first one year of usage while the investigators regularly visited the unit for guidance and supervision. Clients were counseled on the purpose of the study and informed that participation in the study was voluntary.
The data sheet were designed to allow for the clients' demographic data, parity, contraceptive method last used and menstrual pattern on presentation prior to Jadelle use to be obtained. The client's blood pressure and body weight were also measured on presentation. At 6months and 12months of usage, the prevailing menstrual pattern, non-menstrual side effects, the body weight and blood pressure were reassessed by the same set of nurses using standard techniques and recorded in the data sheet.
Data generated from the study were coded and entered into the software of the Statistical Package for Social Sciences (SPSS), Version 17 Inc. Chicago, Ilinois, USA. The data are presented in numerical, percentages and simple proportion, and descriptive and inferential statistics were performed for continuous variables. Longitudinal comparisons were done at 6 months and 12 months for clinical parameters and side effects among clients and differences were considered significant at Pvalues of less than 0.05.
RESULTS
During the 2 year period of the study, there were 2432 clients using different methods of contraception in the family planning unit of the University of Uyo Teaching hospital. Clients who used dermal implants during the period were 196 in number, with 158 of them using Jadelle, giving a method utilization rate of 6.5%. Only 132 of the Jadelle users volunteered and participated to the end of the study and therefore constitute the study population. The menstrual pattern, changes in blood pressure and alterations in body weight of clients during the 12 months period under review is shown in Table 2 . There was a statistically significant alteration in the menstrual pattern of clients to irregular uterine bleeding (31.1%) from the 6month of usage, whereas amenorrhea in 16.6% of clients only occurred from the 12 months usage. Changes in blood pressure and body weight of clients were not significant during the period of the survey. Table 3 shows the non-menstrual side effects of Jadelle among users during the 12 months longitudinal survey. Non menstrual side effects were noted in clients from the 6months of usage, but there was a drop in the proportion of clients who had these side effects by the 12month of the survey, although, the difference was not statistically significant.
DISCUSSION
The invention and improvements on subdermal implants as a method of fertility regulation in sexually active women the world over has made Jadelle a contraceptive method of choice. This is occasioned by its high efficacy, safety profile, reversible long term protection and widespread acceptability by women of all races, notwithstanding, the few tolerable side effects. The proportion of clients who used Jadelle implants in the study centre during the study period was 6.5%, lower than a prevalence of 16.8% obtained 3years earlier in the same unit. 3 The reason for the drop in utilization rate of Jadelle implant is not clear, although it is to be noted that the earlier study covered a period of 4years. During the 12 months longitudinal survey of clients, there was no request for discontinuation of the implant and no accidental pregnancy occurred, in agreement with findings from several other studies. 3, 4, 23, 24 The majority (40.1%) of Jadelle users in the study population were multiparous married (68.9%) women with a mean age of 36.11 + 1.53, and 46.2% of them had attained post-secondary level of education. These clients' demographic parameters were comparable to those of Jadelle users in Port Harcourt, Nigeria where the majority of the clients in that series were multiparous women with a mean age of 33.1years. Notwithstanding, most (89.33%) of the clients in the Port Harcourt series were married with 69.33% having attained post-secondary level of education. 23 In contrast, a study in Thailand had clients with a younger mean age of 29.07years, and most of them were educated only to the secondary level. 4 During the 12 months longitudinal survey, a large proportion of clients had their menstrual pattern disrupted with 30.3% developing irregular uterine bleeding by the 6month of usage and 16.6% becoming amenorrheic from the 12month of usage. (p= 0.000) This trend is noted in all studies where the side effects of Jadelle implants were assessed. 4, [23] [24] [25] [26] In a study in Thailand where Jadelle users with irregular uterine bleeding were randomized into celecoxib drug and placebo groups, those on celecoxib had improved irregular uterine bleeding with higher levels of satisfaction than clients on placebo (p< 0.001). 27 This intervention should probably be considered in order to ameliorate the impact of Jadelle on clients' menstrual function. Similar to results from other studies where the side effects of Jadelle were assessed, our study failed to show any significant changes in blood pressure and body weight during the 12 month longitudinal survey of clients. 4, 23 However, studies in Asia showed significant weight gain in some clients warranting request for removal of the implant, while a study in Pakistan found significant increase in mean body weight of clients by the end of 2 years of usage. 23, 28 There were a few non-menstrual side effects in Jadelle users in this study noted at 6months of usage, although the proportion of clients who had these side effects by the 12month of survey decreased, in agreement with similar studies elsewhere in the world. 4, 25, 26 Conversely, a different study found in addition more serious side effects like upper limb neuropathies, nervousness, visual disturbances, arthropathies, and non-clinical depression. 26 Such symptoms seem to be duration-dependent as they were noted in the 4 th and 5 th years of usage in that series.
In conclusion, Jadelle implant proved highly effective, safe and acceptable to Nigerian clients during the period of the study. While it significantly disrupted the menstrual pattern of clients, none of them opted for discontinuation of the method during the study period. The impact of Jadelle on the blood pressure, body weight and non-menstrual side effects of clients were not remarkable.
